摘要:
A wound closure system and a method of closing a wound are disclosed. The disclosure is directed to a wound closure system comprising a skin anchor mechanically attached to external skin tissue on a first side of a generally linear wound, an anchorable tensioning apparatus mechanically attached to external skin tissue on an opposite side of the wound, and a line extending between the skin anchor and the tensioning apparatus to movably connect the anchor to the tensioning apparatus. The line is fixedly engaged with an anchor on one side of the wound while the tensioning apparatus provides tension on the line to draw the skin anchor and the tensioning apparatus toward each other and toward the wound.
摘要:
A wound closure system and a method of closing a wound are disclosed. The wound closure system includes a plurality of skin anchors mechanically attached to external skin tissue around a periphery of a wound, a line extending between the skin anchors, the line slidably engaged with each skin anchor, and a biasing member that provides tension on the line to draw all of the skin anchors toward the wound. The method of closing a wound includes the steps of attaching a plurality of skin anchors to external skin around a periphery of a wound, extending a line between the skin anchors around substantially the entire periphery of the wound, and providing tension to the line to draw the skin anchors toward the wound.
摘要:
A selectively loadable/sealable bioresorbable carrier assembly for retaining and positioning elements used in brachytherapy procedures comprises a bioresorbable tube having a closed distal end and a proximal open end. The bioresorbable tube is loaded with a selectable arrangement of elements, including at least one radioactive seed, through the proximal open end. After the bioresorbable tube is selectably loaded, the bioresorbable tube is heat sealed at a sealing position adjacent a proximalmost element. Once sealed, the bioresorbable tube maintains the arrangement of elements throughout the treatment duration.
摘要:
An automated implantation system assists the implantation of low dose radioisotope seeds in a patient as part of a brachytherapy procedure. A Z-axis automated motion control system and an X-Y axis automated motion control system control a needle assembly. The X-Y axis automated motion control system positions an insertion axis of the needle assembly relative to the patient. The Z-axis automated motion control system selectively moves the needle assembly along the insertion axis to implant at least one radioisotope seed. This process is repeated for a plurality of locations on a base plane perpendicular to the insertion axis. Preferably, the radioisotope seeds are contained in a replaceable cartridge and the needle assembly is also replaceable.
摘要:
A hinged electronic device (100) includes housing hinge mechanism (130) holding together a first housing section (110) with a first screen portion (160) of a hinged screen (150) and a second housing section (120) with a recess (184) for a second screen portion (170) of the hinged screen (150). The first screen portion (160) and the second screen portion (170) are held together by a screen hinge mechanism (480). When the hinged electronic device (100) is closed, the hinged screen (150) is in a stowed position. When the hinged electronic device (100) is fully opened, the hinged screen (150) is in a fully deployed position, which has the first screen portion (160) and the second screen portion (170) within a single plane.
摘要:
A process for the preparation of diverse known and novel cannabinoids (5), which include cannabinol (CBN, 1), cannabinolic acid (CBNA, 2), cannabivarin (CBV, 3) and cannabivarinic acid (CBVA, 4) and other naturally occurring monocyclic and tricyclic cannabinoids and other analogues from simple inexpensive starting materials using a cascade sequence of allylic rearrangement, aromatization and, as appropriate, further highly selective cyclization reactions. Additionally, cannabinoids of the formula (5) and intermediates of the formula (9) form part of the invention. Use of medicaments comprising one or more of the disclosed cannabinoids alone or admixed with one or more other cannabinoids is also disclosed.